| |
| |
|
| Insider
Information: |
Levin Arthur A |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
16,504 |
|
|
Indirect Shares
|
271,851 |
|
|
| Direct
Value |
$502,877 |
|
|
|
Indirect Value
|
$7,519,689 |
|
|
| Total
Shares |
288,355 |
|
|
| Total
Value |
$8,022,565 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 55.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Vice President |
2007-04-25 |
1,674 |
2003-07-01 |
0 |
Premium* |
|
|
Stoke Therapeutics, Inc. |
STOK |
Director |
2021-03-01 |
0 |
2021-03-01 |
17,979 |
Premium* |
|
|
Avidity Biosciences, Inc. |
RNA |
Director |
2024-05-20 |
14,830 |
2024-05-20 |
253,872 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
71 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| STOK |
Stoke Therapeutics, Inc. |
Director |
– • – |
2021-03-01 |
4 |
OE |
$0.40 |
$6,576 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
Director |
– • – |
2021-03-01 |
4 |
AS |
$60.55 |
$759,841 |
D/D |
(12,500) |
0 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2022-08-12 |
4 |
AS |
$22.00 |
$308,066 |
D/D |
(14,003) |
1,330 |
0 |
% |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2022-08-12 |
4 |
OE |
$0.53 |
$7,422 |
D/D |
14,003 |
15,333 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
16,751 |
310,894 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2023-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
19,330 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2006-11-09 |
4 |
OE |
$6.81 |
$136,200 |
D/D |
20,000 |
21,674 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2006-11-09 |
4 |
AS |
$10.13 |
$202,600 |
D/D |
(20,000) |
1,674 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Director |
– • – |
2024-04-03 |
4 |
S |
$27.11 |
$542,214 |
I/I |
(20,000) |
253,872 |
0 |
% |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2021-06-25 |
4 |
AS |
$27.97 |
$565,299 |
D/D |
(20,100) |
1,330 |
0 |
% |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2021-06-25 |
4 |
OE |
$0.53 |
$22,735 |
D/D |
20,100 |
21,430 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Director |
– • – |
2024-03-12 |
4 |
OE |
$1.24 |
$31,000 |
D/D |
25,000 |
42,471 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Director |
– • – |
2024-03-12 |
4 |
S |
$22.00 |
$609,017 |
D/D |
(27,641) |
14,830 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2006-11-13 |
4 |
AS |
$13.36 |
$400,800 |
D/D |
(30,000) |
1,674 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2006-11-13 |
4 |
OE |
$6.81 |
$204,300 |
D/D |
30,000 |
31,674 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2021-03-05 |
4 |
GA |
$0.00 |
$0 |
I/I |
37,022 |
37,022 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2021-03-05 |
4 |
GD |
$0.00 |
$0 |
I/I |
37,022 |
273,872 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2022-12-29 |
4 |
AS |
$22.01 |
$880,568 |
D/D |
(40,000) |
1,330 |
0 |
% |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2022-12-29 |
4 |
OE |
$1.24 |
$49,600 |
D/D |
40,000 |
41,330 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2022-08-15 |
4 |
AS |
$22.12 |
$1,382,343 |
D/D |
(62,498) |
1,330 |
0 |
% |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2022-08-15 |
4 |
OE |
$0.53 |
$57,802 |
D/D |
62,498 |
63,828 |
0 |
- |
|
71 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
